bFGF and tumor angiogenesis — Back in the limelight?

1. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353−364 (1996). | Article | PubMed  | ISI | ChemPort |
2. Kerbel, R.S. Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anticancer therapeutic agents. BioEssays 13, 31−36 (1991). | PubMed  | ISI | ChemPort |
3. Czubayko, F. et al. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nature Med. 3, 1137−1140 (1997). | Article | PubMed  | ISI | ChemPort |
4. Risau, W. What, if anything, is an angiogenic factor?. Cancer Metastasis Rev. 15, 149−151 (1996). | PubMed  | ISI | ChemPort |
5. Wu, D.Q. et al. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J. Biol. Chem. 266, 16778−16785 (1991). | PubMed  | ISI | ChemPort |
6. Czubayko, F., Smith, R.V., Chung, H.C. & Wellstein, A. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J. Biol. Chem. 269, 28243−28248 (1994). | PubMed  | ISI | ChemPort |
7. Friesel, R.E. & Maciag, T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9, 919−925 (1995). | PubMed  | ISI | ChemPort |
8. Kandel, J. et al. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66, 1095−1104 (1991). | Article | PubMed  | ISI | ChemPort |
9. Cheng, S.Y. et al. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. U.S.A. 93, 8502−8507 (1996). | Article | PubMed  | ChemPort |
10. Rak, J. et al. Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev. 14, 263−277 (1995). | PubMed  | ISI | ChemPort |
11. Bouck, N., Stellmach, V. & Hsu, S.C. How tumors become angiogenic. Adv. Cancer Res. 69, 135−174 (1996). | PubMed  | ISI | ChemPort |
12. Stavri, G.T. et al. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle Cells. Circulation 92, 11−14 (1995). | PubMed  | ISI | ChemPort |
13. Goto, F., Goto, K. & Folkman, J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial Cells within collagen gels. Lab. Invest. 69, 508−517 (1993). | PubMed  | ISI | ChemPort |
14. Asahara, T. et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92, 365−371 (1995). | ISI | ChemPort |
15. Millauer, B. et al. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56, 1615−1620 (1996). | PubMed  | ISI | ChemPort |
16. Warren, R.S. et al. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95, 1789−1797 (1995). | PubMed  | ISI | ChemPort |
17. Yuan, F. et al. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. U.S.A. 93, 14765−14770 (1996). | Article | PubMed  | ChemPort |

	Top

	Top